Dr Shari B Diamond, MD | |
2021 K St Nw, Suite 300, Washington, DC 20006-1003 | |
(301) 942-7600 | |
(202) 419-0418 |
Full Name | Dr Shari B Diamond |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 23 Years |
Location | 2021 K St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326165697 | NPI | - | NPPES |
714874 | Other | AETNA | |
0012 | Other | DC | CAREFIRST OF DC |
2166776 | Other | UNITED HEALTHCARE | |
860441 | Other | NCPPO | |
2166776 | Other | MAMSI | |
897293 01 | Other | MD | CAREFIRST OF MARYLAND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MD034796 (District Of Columbia) | Primary |
207RR0500X | Internal Medicine - Rheumatology | D0065721 (Maryland) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arthritis And Rheumatism Associates Pc | 5597750703 | 49 |
News Archive
While obstetrical care providers are doing a good job working with their patients on smoking cessation, they are not doing as well on abuse of other substances that can harm a woman's unborn baby. A new study appearing in the September 2008 issue of the journal Patient Education and Counseling reports that patients don't volunteer information about substance abuse unless specifically queried.
Late-breaking results from the ElectroCRT trial presented today at EHRA 2019 a European Society of Cardiology congress, pave the way for a new standard of care to improve the heart's pump function in selected patients with heart failure.
Gilead Sciences, Inc. and Yale School of Medicine today announced the formation of a multi-year research collaboration focused on the discovery of novel cancer therapies. The research effort will initially span four years with an option to renew for up to ten years.
NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant efficacy in the recently completed preliminary cell culture studies. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.
Oregon State University researchers have come up with nanoclusters that are capable of reaching within tumours that are difficult to reach. The results of this breakthrough in cancer therapeutics were published in a study in the latest issue of the journal ACS Nano.
› Verified 4 days ago
Entity Name | Arthritis And Rheumatism Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447259866 PECOS PAC ID: 5597750703 Enrollment ID: O20040417000032 |
News Archive
While obstetrical care providers are doing a good job working with their patients on smoking cessation, they are not doing as well on abuse of other substances that can harm a woman's unborn baby. A new study appearing in the September 2008 issue of the journal Patient Education and Counseling reports that patients don't volunteer information about substance abuse unless specifically queried.
Late-breaking results from the ElectroCRT trial presented today at EHRA 2019 a European Society of Cardiology congress, pave the way for a new standard of care to improve the heart's pump function in selected patients with heart failure.
Gilead Sciences, Inc. and Yale School of Medicine today announced the formation of a multi-year research collaboration focused on the discovery of novel cancer therapies. The research effort will initially span four years with an option to renew for up to ten years.
NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant efficacy in the recently completed preliminary cell culture studies. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.
Oregon State University researchers have come up with nanoclusters that are capable of reaching within tumours that are difficult to reach. The results of this breakthrough in cancer therapeutics were published in a study in the latest issue of the journal ACS Nano.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shari B Diamond, MD 2730 University Blvd W, Suite 310, Wheaton, MD 20902-1905 Ph: (301) 942-7600 | Dr Shari B Diamond, MD 2021 K St Nw, Suite 300, Washington, DC 20006-1003 Ph: (301) 942-7600 |
News Archive
While obstetrical care providers are doing a good job working with their patients on smoking cessation, they are not doing as well on abuse of other substances that can harm a woman's unborn baby. A new study appearing in the September 2008 issue of the journal Patient Education and Counseling reports that patients don't volunteer information about substance abuse unless specifically queried.
Late-breaking results from the ElectroCRT trial presented today at EHRA 2019 a European Society of Cardiology congress, pave the way for a new standard of care to improve the heart's pump function in selected patients with heart failure.
Gilead Sciences, Inc. and Yale School of Medicine today announced the formation of a multi-year research collaboration focused on the discovery of novel cancer therapies. The research effort will initially span four years with an option to renew for up to ten years.
NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant efficacy in the recently completed preliminary cell culture studies. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.
Oregon State University researchers have come up with nanoclusters that are capable of reaching within tumours that are difficult to reach. The results of this breakthrough in cancer therapeutics were published in a study in the latest issue of the journal ACS Nano.
› Verified 4 days ago
Dr. Adefolaju Oketokun, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |